Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lobe Sciences Ltd Ordinary Shares GTSIF

Healthcare Drug Manufacturers - Specialty & Generic
Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.

Recent & Breaking News (OTCPK:GTSIF)

Greenstar Biosciences Signs Agreement to Acquire 100% of Eleusian Biosciences Corp.

Newsfile June 16, 2020

GreenStar Biosciences Announces Stock Option Issuance and Cancellation of Stock Options

Newsfile May 25, 2020

GreenStar Biosciences Announces Resignation of Independent Board Member

Newsfile April 17, 2020

GreenStar Biosciences' Cowlitz Reports Record Breaking Revenues of US$19.5 M for 2019

Newsfile March 2, 2020

GreenStar Biosciences Announces New CEO and Board Changes

Newsfile February 24, 2020

Greenstar Biosciences Announces Grant of Stock Options

Newsfile January 17, 2020

Greenstar Biosciences Provides Corporate Update

Newsfile December 20, 2019

GreenStar Biosciences Comments on Market Activity

Newsfile December 10, 2019

GreenStar Biosciences Announces Transformational Phase One Expansion at Cowlitz

Newsfile December 2, 2019

GreenStar Biosciences Announces Achievement of DTC Eligibility

Newsfile November 21, 2019

Strength in Numbers: The Name You Don't Know in Cannabis, But Should ... GreenStar Biosciences -- CFN Media

Newsfile November 20, 2019

Greenstar Biosciences Achieves OTC Listing

Newsfile October 10, 2019